share_log

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $14

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Lowers Price Target to $14

HC Wainwright & Co.维持对ProPhase Labs的买入,将目标价下调至14美元
Benzinga ·  2023/05/12 09:00

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and lowers the price target from $15 to $14.

HC Wainwright & Co. 分析师陈毅维持ProPhase Labs(纳斯达克股票代码:PRPH)的买入,并将目标股价从15美元下调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发